XML 50 R30.htm IDEA: XBRL DOCUMENT v3.6.0.2
Collaboration and License Agreements (Tables)
 12 Months Ended
Dec. 31, 2016
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Summary of Revenue from Collaboration and License Agreements

We have recognized revenue from our collaboration and license agreements as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2016

 

 

2015

 

 

2014

 

BMS and Pfizer

 

$

6,583

 

 

$

1,540

 

 

$

1,497

 

Daiichi Sankyo

 

 

10,421

 

 

 

4,578

 

 

 

4,287

 

Bayer and Janssen

 

 

8,248

 

 

 

5,740

 

 

 

3,598

 

Bayer

 

 

1,450

 

 

 

–

 

 

 

–

 

Dermavant

 

 

8,750

 

 

 

–

 

 

 

–

 

Other

 

 

52

 

 

 

212

 

 

 

243

 

Total collaboration and license revenue

 

$

35,504

 

 

$

12,070

 

 

$

9,625